QuantRx Biomedical Corporation
QTXB
$0.0005
$0.0003150.00%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -14.12% | 15.95% | -28.00% | -27.47% | -20.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.12% | 15.95% | -28.00% | -27.47% | -20.56% |
| Operating Income | 14.12% | -15.95% | 28.00% | 27.47% | 20.56% |
| Income Before Tax | 2.86% | -4.94% | 2.54% | 4.09% | 3.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2.86% | -4.94% | 2.54% | 4.09% | 3.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.86% | -4.94% | 2.54% | 4.09% | 3.37% |
| EBIT | 14.12% | -15.95% | 28.00% | 27.47% | 20.56% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Normalized Basic EPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS Diluted | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Normalized Diluted EPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
